-
Traders Alert: Encana Corporation (NYSE:ECA), Chicago Bridge & Iron Company (NYSE:CBI), BBVA Banco Frances SA (NYSE:BFR), Intervest Bancshares (NASDAQ:IBCA), Lear Corp. (NYSE:LEA)
Deutsche Bank downgraded shares of Encana Corporation (NYSE:ECA) from a buy rating to a hold rating in a report issued on Friday. They currently have C$18.00 target price on the stock, down from their previous target price of C$21.00.On Friday shares of Encana Corporation (NYSE:ECA) closed at $12.24. Company’s sales growth for last 5 years…
-
Top News: Gilead Sciences Inc. (NASDAQ:GILD), Boston Scientific Corporation (NYSE:BSX), Resource Capital Corp. (NYSE:RSO), Celanese Corporation (NYSE:CE), BBVA Banco Frances SA (NYSE:BFR)
On 16 January U.S.-based Gilead Sciences Inc (NASDAQ:GILD) appeal the Indian patent office’s rejection of its application for hepatitis C drug Sovaldi, a move that could allow local drugmakers to launch cheaper generic versions of the $1,000-a-pill medicine. On Wednesday shares of Gilead Sciences Inc. (NASDAQ:GILD) closed at $103.58. Company’s sales growth for last 5…
-
Market Watch: J C Penney Company Inc (NYSE:JCP), Flextronics International (NASDAQ:FLEX), BBVA Banco Frances SA (NYSE:BFR), BIOLASE (NASDAQ:BIOL), Chimerix (NASDAQ:CMRX)
J C Penney Company Inc (NYSE:JCP) provided a preliminary update Tuesday on the company’s performance for the combined nine-week November and December period. The company reported comparable store sales growth of 3.7 percent over the same period last year.J C Penney Company Inc (NYSE:JCP) in last trading activity moved up 1.86% to close at $6.56.…
-
Stocks to Keep Eyes On: Gilead Sciences (NASDAQ:GILD), ArcelorMittal SA (ADR) (NYSE:MT), BBVA Banco Frances (NYSE:BFR), IGI, Laboratories (NYSEMKT:IG), CVD Equipment (NASDAQ:CVV)
Gilead Sciences Inc. (NASDAQ:GILD) agreed to make its hepatitis C medicines the exclusive treatments for CVS Health Corp. (CVS) customers, intensifying a drug-industry rivalry to win patients for the $1,000-a-day medicines. Gilead Sciences Inc. (NASDAQ:GILD) in last trading activity moved up 1.98% to close at $96.79. Company weekly performance is 3.19% while its quarterly performance…